Understanding Insufficient GLP-1 Activity in T2D

T2D: Don’t Sugar Coat It

English - January 03, 2022 05:00 - 9 minutes - 8.48 MB - ★★★★★ - 3 ratings
Science Education intervention a1c alpha cell weight reduction beta cell beta-cell dysfunction blood sugar cardiovascular glp-1 cardiovascular disease Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Role of Endogenous GLP-1

Next Episode: The Increased Risk of Cardiovascular Disease in Patients With T2D

What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

This podcast is sponsored by Novo Nordisk and is intended for clinicians.

Faculty Presenters:

John E. Anderson, MD
Internal Medicine and Diabetes
The Frist Clinic
Nashville, Tennessee

Javier Morales, MD, FACP, FACE
Internal Medicine, Diabetes, and Primary Care
Associate Clinical Professor
Hofstra/Northwell School of Medicine at the Donald and Barbara Zucker School of Medicine
Long Island, New York

Richard E. Pratley, MD
Internal Medicine and Diabetes
AdventHealth Diabetes Institute
Orlando, Florida